Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

412 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Thromboprophylaxis in people hospitalized with COVID-19: Assessing intermediate or standard doses in a retrospective cohort study.
Andersen KM, Joseph CS, Mehta HB, Streiff MB, Betz JF, Bollinger RC Jr, Fisher AM, Gupta A, LeMaistre CF, Robinson ML, Xu Y, Ng DK, Alexander GC, Garibaldi BT. Andersen KM, et al. Among authors: ng dk. Res Pract Thromb Haemost. 2022 Jul 15;6(5):e12753. doi: 10.1002/rth2.12753. eCollection 2022 Jul. Res Pract Thromb Haemost. 2022. PMID: 35859579 Free PMC article.
Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort Collaborative.
Andersen KM, Bates BA, Rashidi ES, Olex AL, Mannon RB, Patel RC, Singh J, Sun J, Auwaerter PG, Ng DK, Segal JB, Garibaldi BT, Mehta HB, Alexander GC; National COVID Cohort Collaborative Consortium. Andersen KM, et al. Among authors: ng dk. Lancet Rheumatol. 2022 Jan;4(1):e33-e41. doi: 10.1016/S2665-9913(21)00325-8. Epub 2021 Nov 15. Lancet Rheumatol. 2022. PMID: 34806036 Free PMC article.
Dendrimer nanotherapy for severe COVID-19 attenuates inflammation and neurological injury markers and improves outcomes in a phase2a clinical trial.
Gusdon AM, Faraday N, Aita JS, Kumar S, Mehta I, Choi HA, Cleland JL, Robinson K, McCullough LD, Ng DK, Kannan RM, Kannan S. Gusdon AM, et al. Among authors: ng dk. Sci Transl Med. 2022 Jul 20;14(654):eabo2652. doi: 10.1126/scitranslmed.abo2652. Epub 2022 Jul 20. Sci Transl Med. 2022. PMID: 35857827 Free article. Clinical Trial.
Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial.
Fisher CJ Jr, Slotman GJ, Opal SM, Pribble JP, Bone RC, Emmanuel G, Ng D, Bloedow DC, Catalano MA; IL-1RA Sepsis Syndrome Study Group. Fisher CJ Jr, et al. Crit Care Med. 1994 Jan;22(1):12-21. doi: 10.1097/00003246-199401000-00008. Crit Care Med. 1994. PMID: 8124953 Clinical Trial.
412 results